1
|
Panina A, Kaidarova D, Zholdybay Z, Ainakulova A, Amankulov J, Toleshbayev D, Zhakenova Z, Khozhayev A. Lung cancer screening with low-dose chest computed tomography: experience from radon contaminated regions in Kazakhstan. J Prev Med Public Health 2022; 55:273-279. [PMID: 35678001 PMCID: PMC9201089 DOI: 10.3961/jpmph.21.600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2021] [Accepted: 03/23/2022] [Indexed: 11/09/2022] Open
Affiliation(s)
- Alexandra Panina
- Kazakh Institute of Oncology and Radiology, Almaty,
Kazakhstan
- Asfendiyarov Kazakh National Medical University, Almaty,
Kazakhstan
| | - Dilyara Kaidarova
- Kazakh Institute of Oncology and Radiology, Almaty,
Kazakhstan
- Asfendiyarov Kazakh National Medical University, Almaty,
Kazakhstan
| | | | - Akmaral Ainakulova
- Kazakh Institute of Oncology and Radiology, Almaty,
Kazakhstan
- Asfendiyarov Kazakh National Medical University, Almaty,
Kazakhstan
| | - Jandos Amankulov
- Kazakh Institute of Oncology and Radiology, Almaty,
Kazakhstan
- Asfendiyarov Kazakh National Medical University, Almaty,
Kazakhstan
| | - Dias Toleshbayev
- Kazakh Institute of Oncology and Radiology, Almaty,
Kazakhstan
- Asfendiyarov Kazakh National Medical University, Almaty,
Kazakhstan
| | - Zhanar Zhakenova
- Asfendiyarov Kazakh National Medical University, Almaty,
Kazakhstan
| | - Arman Khozhayev
- Asfendiyarov Kazakh National Medical University, Almaty,
Kazakhstan
| |
Collapse
|
2
|
Mauyenova D, Zhadykova Y, Khozhayev A, Turebayev D, Kulmirzayeva D, Urazova S, Nurtazinova G, Kuandykov Y, Amanshayeva A, Sakhanov S, Bukeyeva Z, Openko V, Orazbayev S, Kozhakhmetov S, Bilyalova Z, Igissinova G, Alireza Mosavi Jarrahi A, Igissinov N. Trends of Colorectal Cancer Incidence in Kazakhstan. Asian Pac J Cancer Prev 2021; 22:3405. [PMID: 34714614 PMCID: PMC8858261 DOI: 10.31557/apjcp.2021.22.10.3405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Abstract
Background and objective: Colorectal cancer (CRC) remains one of the most widespread human malignancies. The aim of this study was to study trends of the incidence of CRC in Kazakhstan. Materials and Method: This retrospective study was done using descriptive and analytical methods of oncoepidemiology. Results: During the study period from 2009 to 2018, 28,950 new cases of CRC were recorded, 13,779 (47.6%) cases were allocated to men and 15,171 (52.4%) to women. It was found that the incidence rate of CRC increased from 14.79 (2009) to 17.72 in 2018 and the overall growth was 2.93 cases per 100,000. This increase was due to the age structure – ∑ΔA=+1.42, the risk of acquiring illness – ∑ΔR=+1.31, and their combined effect – ∑ΔRA=+0.20. The component analysis results revealed that the increase in the number of patients with CRC was mainly due to the growth of the population (ΔP=+37.7%), changes in age structure (ΔA=+26.6%), and changes associated with the risk of acquiring illness (ΔR=+24.6%). The number of patients (both sexes) was increasing in many regions largely due to the influence of the age structure of the population. In addition, it was found that growth in the number of patients in most regions, both men and women, was associated primarily with the risk of acquiring illness. Conclusion: The findings of the current study showed increasing trends in the incidence of CRC in all regions of the country. These changes were mainly influenced by demographic factors (population size and age structure), risk of acquiring the disease, and their combined effect.
Collapse
Affiliation(s)
- Dana Mauyenova
- Astana Medical University, Nur-Sultan, Kazakhstan.,Central Asian Cancer Institute, Nur-Sultan, Kazakhstan
| | - Yerkezhan Zhadykova
- Astana Medical University, Nur-Sultan, Kazakhstan.,Central Asian Cancer Institute, Nur-Sultan, Kazakhstan
| | - Arman Khozhayev
- Department of Oncology, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
| | - Dulat Turebayev
- Astana Medical University, Nur-Sultan, Kazakhstan.,Central Asian Cancer Institute, Nur-Sultan, Kazakhstan
| | - Dariyana Kulmirzayeva
- Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.,National Center for Neurosurgery, Nur-Sultan, Kazakhstan
| | - Saltanat Urazova
- Astana Medical University, Nur-Sultan, Kazakhstan.,Central Asian Cancer Institute, Nur-Sultan, Kazakhstan
| | - Gaukhar Nurtazinova
- Astana Medical University, Nur-Sultan, Kazakhstan.,Central Asian Cancer Institute, Nur-Sultan, Kazakhstan
| | - Yerlan Kuandykov
- Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.,Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkistan, Kazakhstan
| | | | - Sauirbay Sakhanov
- Astana Medical University, Nur-Sultan, Kazakhstan.,Central Asian Cancer Institute, Nur-Sultan, Kazakhstan
| | - Zhanar Bukeyeva
- Astana Medical University, Nur-Sultan, Kazakhstan.,Central Asian Cancer Institute, Nur-Sultan, Kazakhstan
| | - Vladimir Openko
- Astana Medical University, Nur-Sultan, Kazakhstan.,Central Asian Cancer Institute, Nur-Sultan, Kazakhstan
| | - Serikbay Orazbayev
- Astana Medical University, Nur-Sultan, Kazakhstan.,Central Asian Cancer Institute, Nur-Sultan, Kazakhstan
| | - Saken Kozhakhmetov
- Astana Medical University, Nur-Sultan, Kazakhstan.,Central Asian Cancer Institute, Nur-Sultan, Kazakhstan
| | | | - Gulnur Igissinova
- Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.,Department of Oncology, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
| | | | - Nurbek Igissinov
- Astana Medical University, Nur-Sultan, Kazakhstan.,Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.,Eurasian Institute for Cancer Research, Bishkek, Kyrgyzstan
| |
Collapse
|
3
|
Toguzbayeva A, Telmanova Z, Khozhayev A, Jakipbayeva A, Aimbetova G, Zhantureyeva A, Bilyalova Z, Urazova S, Igissinova G, Turdaliyeva B, Moore MA, Igissinov NS. Impact of Screening on Breast Cancer Incidence in Kazakhstan: Results of Component Analysis. Asian Pac J Cancer Prev 2021; 22:2807-2817. [PMID: 34582649 PMCID: PMC8850875 DOI: 10.31557/apjcp.2021.22.9.2807] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2021] [Indexed: 11/25/2022] Open
Abstract
OBJECTIVE The study is to conduct a component analysis of the dynamics of the incidence of BC (BC) in Kazakhstan, taking into account regions. METHODS Primary data were for registered patients with BC (ICD 10 - C50) in the whole country during the period of 2009-2018. Evaluation of changes in BC incidence in the population of Kazakhstan was performed using component analysis according to the methodological recommendations. RESULTS The study period, 40,199 new cases of BC were recorded. The incidence rate increased from 39.5 (2009) to 49.6 in 2018 and the overall growth was 2.8 per 100,000 population of female, including due to the age structure - ∑ΔA=+2.99, due to the risk of acquiring illness - ∑ΔR=+6.82 and their combined effect - ∑ΔRA=+0.31. The component analysis revealed that the increase in the number of patients with BC was mainly due to the growth of the population (ΔP=+31.1%), changes in its age structure (ΔA=+18.0%) and changes associated with the risk of acquiring illness (ΔR=+41.0%). The increase in the number of patients in the regions of the republic is associated with the influence of demographic factors and with risk factors for getting sick, including mammographic screening. CONCLUSION Thus, as a result of the component analysis, the role of the influence of demographic factors and the risk of acquiring illness on the formation of the number of patients and the incidence of BC was evaluated, while geographical variability was established. This research was the first epidemiological study of the dynamics of BC in the regional context by the method of component analysis in the population of Kazakhstan. The implementation of the results of this study is recommended in management of anticancer activities for BC.
Collapse
Affiliation(s)
- Assem Toguzbayeva
- Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.,Central Asian Cancer Institute, Nur-Sultan, Kazakhstan
| | - Zhansaya Telmanova
- Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.,Astana Medical University, Nur-Sultan, Kazakhstan
| | - Arman Khozhayev
- Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
| | | | | | | | | | - Saltanat Urazova
- Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.,Astana Medical University, Nur-Sultan, Kazakhstan
| | - Gulnur Igissinova
- Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.,Central Asian Cancer Institute, Nur-Sultan, Kazakhstan
| | | | | | - Nurbek Saginbekovich Igissinov
- Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.,Astana Medical University, Nur-Sultan, Kazakhstan.,Eurasian Institute for Cancer Research, Bishkek, Kyrgyzstan
| |
Collapse
|